| Rank | Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 1 | $1.10T | Healthcare | Pharmaceuticals | United States | NYSE | |
| 2 | $618B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 3 | $481B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 4 | $351B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 5 | $273B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 6 | $170B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 7 | $170B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 8 | $159B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 9 | $128B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 10 | $100B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 11 | $98.1B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 12 | $76.1B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 13 | $58.5B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 14 | $32.3B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 15 | $30.2B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 16 | $30.0B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 17 | $24.7B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 18 | $23.2B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 19 | $22.9B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 20 | $21.9B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 21 | $20.0B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 22 | $14.4B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 23 | $13.8B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 24 | $13.7B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 25 | $12.8B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 26 | $12.7B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 27 | $11.3B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 28 | $11.0B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 29 | $10.6B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 30 | $9.05B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 31 | $8.91B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 32 | $8.62B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 33 | $8.58B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 34 | $8.16B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 35 | $7.36B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 36 | $7.20B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 37 | $7.05B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 38 | $6.99B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 39 | $6.73B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 40 | $6.28B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 41 | $6.17B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 42 | $6.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 43 | $6.00B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 44 | $5.88B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 45 | $5.41B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 46 | $5.29B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 47 | $5.28B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 48 | $5.22B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 49 | $5.22B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 50 | $5.12B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 51 | $4.91B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 52 | $4.70B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 53 | $4.61B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 54 | $4.26B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 55 | $4.18B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 56 | $3.81B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 57 | $3.69B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 58 | $3.61B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 59 | $3.50B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 60 | $3.48B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 61 | $3.46B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 62 | $3.37B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 63 | $3.23B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 64 | $3.16B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 65 | $3.08B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 66 | $3.06B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 67 | $3.03B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 68 | $3.03B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 69 | $2.98B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 70 | $2.94B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 71 | $2.72B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 72 | $2.56B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 73 | $2.54B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 74 | $2.51B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 75 | $2.45B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 76 | $2.38B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 77 | $2.33B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 78 | $2.31B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 79 | $2.30B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 80 | $2.27B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 81 | $2.27B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 82 | $2.26B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 83 | $2.19B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 84 | $2.16B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 85 | $2.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 86 | $2.08B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 87 | $2.03B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 88 | $2.01B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 89 | $1.98B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 90 | $1.97B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 91 | $1.92B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 92 | $1.91B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 93 | $1.89B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 94 | $1.87B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 95 | $1.86B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 96 | $1.83B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 97 | $1.82B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 98 | $1.81B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 99 | $1.80B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 100 | $1.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |